Chase BC
Cannabis Project Brief
1186626 BC Ltd.
July 2019
Private & Confidential
The information contained herein is confidential and is provided to its audience solely for the purpose of evaluation of project presented by 1186626 BC Ltd. This information is not to be shared, distributed, or otherwise used, for any other purpose by any other individual, organization, company or business entity, without the prior written permission of 1186626 BC Ltd.
Project Highlight
US $5.2 B
US $40.6 B
Canadian Cannabis Market by 2024
World-wide Cannabis Market by 2024
Source: BDS Analytics - April 9 2019
Disclaimer Statements
This presentation and certain statements may constitute forward- looking statements. Terms such as “expect”, “believe”, “continue”, “going forward”, “expand”, and “grow”, as well as similar comments, are forward-looking in nature. These forward-looking statements include, but are not limited to, references to future capital investment, financial guidance of any kind, business strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of the business and operations, plans and references to the future success or the risk profile of the company. These forward-looking statements are based on certain assumptions and analyses made by management in light of its experience and its perception of historical trends, current conditions and expected future developments as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions are subject to a number of risks and uncertainties including availability and cost of capital, general business and economic conditions, and other factors, many of which are beyond the control of the company. Should one or more of these risks materialize, or should assumptions underlying the forward-looking statements prove incorrect, actual results may vary materially from those as described herein. Consequently, all of the forward-looking statements made in this presentation are qualified by these cautionary statements, and there can be no assurance that actual results or developments anticipated by management will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the company. The information contained in 1186626 B.C. Ltd. marketing materials (the “Marketing Information”) is not part of an offering memorandum, subscription agreement or other such offering document. The Marketing Information may contain references and information about 1186626 B.C. Ltd. The Marketing Information is for informational purposes only. 1186626 B.C. Ltd uses reasonable efforts to provide up to date and accurate information in its marketing materials, however, errors and omissions may occur. Further, any performance data that may be expressed in the Marketing Information is an indication of past performance only and does not indicate or guarantee future results. No information in the Marketing Information should be construed as a solicitation, offer, recommendation, representation of suitability or endorsement of any security or investment. Offerings of securities in BC are made only by a private placement memorandum, offering memorandum or subscription agreement distributed by persons authorized by 1186626 B.C. Ltd
Project Timeline
Interim License Building 1 Complete
First 30,000 sq ft. building constructed, Health Canada issue interim license to cultivate
Dec. 2019
Investment Round
Current investment Round to fund Facility Phase 1 construction
Q3 2019
Land & Late-stage Application Acquired
Land purchased and obtained a late-stage application to fast-track the process
Q1 / Q2 2019
License
First Sale
First crop passes inspection and facility receive approval to sale. Acquire finalized ACMPR LP License.
Q1 2020
Capital Pay-back
Target date to pay back investors’ original capital
July 31, 2021
Dividend Payout Begins
Quarterly Dividend payout begins
Oct. 31, 2021
Indoor Facility
Development Site - Chase BC
$36 Million
Annual Revenue
6,000 kilograms of cannabis
Forecast conservatively based on non-organic wholesale price of $6 /gram
One 30,000 sq. ft. Building
Valuation
Cannabis company valuations are roughly linked to its revenue and revenue-producing potential. Table below shows some Canadian companies and their valuation (market cap). 118 expect our annual revenue at Phase 1 completion to be $180 million ($36M per building x 5 buildings)
| Licensed Company | 4Q of Revenue ($M) | Market Cap ($M) |
Conventional | Canopy Growth | 290.9 | 11,532 |
Aurora | 170.4 | 7,634 | |
Tilray | 94.5 | 3,669 | |
Aphria | 237.1 | 2,201 | |
HEXO | 33.5 | 1,297 | |
Organigram | 67.3 | 1,070 | |
Supreme | 26.4 | 490 | |
National Access | 1.4 | 84 | |
Sunniva | 27.8 | 40 | |
Organic | Rubicon | 1.2 | 80 |
Green Organic Dutchman | 7.2 | 864 | |
Whistler Medical* acquired by Aurora 01/2019 | 5000kg | 175 |
Project Advantages
Chase BC
Cannabis Project
1186626 BC Ltd.
To Learn More:
Henry Lo (778) 378-5696
Kevin Hu (604) 992-8778
info@1186626bc.com
News Release - Joint Venture